1. Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
   Wattawan Wongpattaraworakul et al, 2022, Frontiers in Oncology CrossRef
2. Targeting immunotherapy for bladder cancer using anti‐CD3× B7‐H3 bispecific antibody
   Wanru Ma et al, 2018, Cancer Medicine CrossRef
3. Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy
   Ran You et al, 2022, Cancer Immunology Research CrossRef
4. Recent advances of bispecific antibodies in solid tumors
   Shengnan Yu et al, 2017, Journal of Hematology & Oncology CrossRef
5. Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
   Yutao Li et al, 2022, International Journal of Molecular Sciences CrossRef
6. Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
   Xingchun Gao et al, 2017, Frontiers in Immunology CrossRef
7. Promising immunotherapy: Highlighting cytokine‐induced killer cells
   Solmaz Shirjang et al, 2019, Journal of Cellular Biochemistry CrossRef
8. How can Cytokine-induced killer cells overcome CAR-T cell limits
   Elisa Cappuzzello et al, 2023, Frontiers in Immunology CrossRef
9. Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment
   Tine Logghe et al, 2024, Cancers CrossRef
10. Cytokine-Induced Killer Cells: A Unique Platform for Adoptive Cell Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation
    Eva Rettinger, 2024, Transfusion Medicine and Hemotherapy CrossRef
11. B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
    Juan Ma et al, 2016, Oncotarget CrossRef
12. Cancer Immunotherapy with Cytokine-Induced Killer Cells
    Juan J. Mata-Molanes et al, 2017, Targeted Oncology CrossRef